Why Swoop

Predictive Audiences

A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Adherence Audiences

With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.

Download

DTC Audiences

Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%

A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.

Download

Products

Television

Swoop TV Marketing Overview

Go Omniglass with Swoop’s TV marketing solutions. Bridge audience fragmentation and maximize your TV strategy across leading channel partners with our omniglass offering.

Download

Swoop Agents

Swoop Agents Overview

Unlock your brand.com first-party data potential. Swoop’s award winning chatbot transforms site level engagement into valuable first-party data with conversational AI.

Download

About Swoop

Swoop

Fierce Pharma 2025: Why a Unified Audience is Your Key to 2026 Success

Patient-first impact: building trust and delivering results

Learn More

DTC Marketing

83% of Chronic Condition Patients Surveyed Find Pharma Ads Beneficial

Patient Perspectives on Pharmaceutical Advertising: Exclusive Insights from Swoop

Learn More

Insights

MyHealthTeam

Empowering Patients: How Pharma Ads Drive Better Health Outcomes

Survey reveals 67% of patients with chronic conditions took an action after seeing treatment advertising

Download

Swoop Agents

From Whispers to Wisdom: AI’s Role in Demystifying IUD Conversations

How Swoop Agents provide patients and providers round-the-clock, accurate information.

Download

Back

MyHealthTeam Research

MyHealthTeam Posters Featured at AANAM 2025

Today, representatives from MyHealthTeam, a Swoop company, presented our latest research featured in two posters at the American Academy of Neurology 2025 Annual Meeting. These latest findings are the most recent examples of how Swoop is transforming patient care.

Patient Reported Attitudes Towards Multiple Sclerosis Treatment

Authors: Dianna Cronin (MyHealthTeam) and Beth Schneider (MyHealthTeam)

OBJECTIVE
Research was undertaken to better understand awareness, usage, and attitudes towards DMTs.

Click the image to download.

Matching Anti-Seizure Medications’ Formulations to Patients: Why It Matters!

Authors: James W. Wheless, BScPharm, M.D., FAAP, FACP, FAAN, FAES, Le Bonheur Children’s Hospital, Heather Lapidus Glassner, MyHealthTeam, Dianna Higgins Cronin, MyHealthTeam

OBJECTIVE
To understand the healthcare provider (HCP) and parent/caregiver dialogue regarding swallowing challenges of anti-seizure medications (ASMs) in children with epilepsy.

Click the image to download.

Our research team delivers rapid patient insights that inform brand strategies. Contact us to learn more.

Swoop
Transforming Omnichannel

Swoop is a market leader in privacy-safe, award-winning omnichannel healthcare marketing solutions. Our platform connects patients, HCPs, and brands at scale across all channels, delivering unmatched engagement and proximity to patients throughout their health journey. By combining AI-driven technology with real-world data (RWD), first- and zero-party data, and engagement data, Swoop empowers pharma marketers to make faster, more precise decisions that improve patient outcomes.